Journey Medical Corporation
US ˙ NasdaqCM ˙ US48115J1097

SecurityDERM / Journey Medical Corporation
InstitutionVanguard Group Inc
Latest Disclosed Ownership764,147 shares
Latest Disclosed Value $ 5,891,574
Vanguard Group Inc reports 24.21% increase in ownership of DERM / Journey Medical Corporation

On January 29, 2026 - Vanguard Group Inc filed a 13F-HR form disclosing ownership of 764,147 shares of Journey Medical Corporation (US:DERM) valued at $5,891,573 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 7, 2025 disclosing 615,229 shares of Journey Medical Corporation. This represents a change in shares of 24.21% during the quarter. The current value of the position is $4,752,994 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F JOURNEY MED COM 48115J109 764,147 148,918 24.21 5,892 34.50 0.0001
2025-11-07 2025-09-30 13F JOURNEY MED COM 48115J109 615,229 50,241 8.89 4,380 7.99 0.0001
2025-08-11 2025-06-30 13F JOURNEY MED COM 48115J109 564,988 192,727 51.77 4,057 84.70 0.0001
2025-05-09 2025-03-31 13F JOURNEY MED COM 48115J109 372,261 47,090 14.48 2,196 72.78 0.0000
2025-02-11 2024-12-31 13F JOURNEY MED COM 48115J109 325,171 0 0.00 1,271 -30.81 0.0000
2024-11-13 2024-09-30 13F JOURNEY MED COM 48115J109 325,171 14,923 4.81 1,837 5.03 0.0000
2024-08-13 2024-06-30 13F JOURNEY MED COM 48115J109 310,248 0 0.00 1,750 53.29 0.0000
2024-05-10 2024-03-31 13F JOURNEY MED COM 48115J109 310,248 180,800 139.67 1,142 53.15 0.0000
2024-03-11 2023-12-31 13F/A-1 JOURNEY MED COM 48115J109 129,448 56,781 78.14 746 274.37 0.0000
2024-02-14 2023-12-31 13F JOURNEY MED COM 48115J109 129,448 56,781 746 0.0000
2023-12-18 2023-09-30 13F/A-1 JOURNEY MED COM 48115J109 72,667 51,634 245.49 199 503.03 0.0000
2023-11-14 2023-09-30 13F JOURNEY MED COM 48115J109 72,667 51,634 199 0.0000
2023-08-14 2023-06-30 13F JOURNEY MED COM 48115J109 21,033 1 0.00 33 0.00 0.0000
2023-07-14 2023-03-31 13F/A-1 JOURNEY MED COM 48115J109 21,032 4,083 24.09 33 3.13 0.0000
2023-05-15 2023-03-31 13F JOURNEY MED COM 48115J109 21,032 4,083 33 0.0000
2023-02-10 2022-12-31 13F JOURNEY MED COM 48115J109 16,949 106 0.63 33 -21.95 0.0000
2022-11-14 2022-09-30 13F JOURNEY MED COM 48115J109 16,843 6,408 61.41 41 5.13 0.0000
2022-08-12 2022-06-30 13F JOURNEY MED COM 48115J109 10,435 10,435 39 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.